# Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

> **NCT04391478** · PHASE1 · COMPLETED · sponsor: **Rania Ali El-Farrash** · enrollment: 40 (actual)

## Conditions studied

- Persistent Pulmonary Hypertension

## Interventions

- **DRUG:** Milrinone
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT04391478
- **Lead sponsor:** Rania Ali El-Farrash
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391478, "Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04391478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*